- Home
- CRNX vs FCFS Comparison
CRNX vs FCFS Comparison
Compare CRNX & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- FCFS
- Stock Information
- Founded
- CRNX 2008
- FCFS 1988
- Country
- CRNX United States
- FCFS United States
- Employees
- CRNX N/A
- FCFS N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- FCFS Other Specialty Stores
- Sector
- CRNX Health Care
- FCFS Consumer Discretionary
- Exchange
- CRNX Nasdaq
- FCFS Nasdaq
- Market Cap
- CRNX 5.3B
- FCFS 4.7B
- IPO Year
- CRNX 2018
- FCFS 1991
- Fundamental
- Price
- CRNX $54.72
- FCFS $105.77
- Analyst Decision
- CRNX Strong Buy
- FCFS Strong Buy
- Analyst Count
- CRNX 10
- FCFS 4
- Target Price
- CRNX $73.70
- FCFS $135.67
- AVG Volume (30 Days)
- CRNX 655.3K
- FCFS 315.3K
- Earning Date
- CRNX 11-12-2024
- FCFS 10-24-2024
- Dividend Yield
- CRNX N/A
- FCFS 1.44%
- EPS Growth
- CRNX N/A
- FCFS 8.11
- EPS
- CRNX N/A
- FCFS 5.41
- Revenue
- CRNX $1,038,999.00
- FCFS $3,356,837,000.00
- Revenue This Year
- CRNX N/A
- FCFS $10.19
- Revenue Next Year
- CRNX $494.25
- FCFS $5.07
- P/E Ratio
- CRNX N/A
- FCFS $19.54
- Revenue Growth
- CRNX N/A
- FCFS 10.10
- 52 Week Low
- CRNX $28.50
- FCFS $101.62
- 52 Week High
- CRNX $62.53
- FCFS $133.64
- Technical
- Relative Strength Index (RSI)
- CRNX 41.37
- FCFS 41.61
- Support Level
- CRNX $58.21
- FCFS $107.43
- Resistance Level
- CRNX $62.53
- FCFS $112.02
- Average True Range (ATR)
- CRNX 2.48
- FCFS 3.09
- MACD
- CRNX -0.33
- FCFS 0.27
- Stochastic Oscillator
- CRNX 4.87
- FCFS 17.62
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Close to 30% of total company revenue comes from interest earned on the loans. Close to 70% of total revenue comes from reselling forfeited property in the company's retail stores.